Company Filing History:
Years Active: 2019-2024
Title: The Innovative Contributions of Matthew N Alder
Introduction
Matthew N Alder is a prominent inventor based in Birmingham, AL (US). He has made significant contributions to the field of biotechnology, particularly in the development of variable lymphocyte receptors (VLRs). With a total of 3 patents to his name, Alder's work has the potential to impact various medical applications.
Latest Patents
One of Alder's latest patents focuses on methods and compositions related to soluble monoclonal variable lymphocyte receptors of defined antigen specificity. This patent discloses a variety of antigen-specific polypeptides, including soluble, monoclonal, and multivalent forms. The methods outlined in this patent include the use of these polypeptides, antibodies that bind to them, and the nucleic acids, vectors, and expression systems that encode these polypeptides. Notably, the patent highlights antigen-specific polypeptides that selectively bind pathogens, such as anthrax, and carbohydrates, including blood group determinants.
Career Highlights
Matthew N Alder is associated with the UAB Research Foundation, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential applications in immunology and therapeutic development.
Collaborations
Alder has collaborated with notable figures in the field, including Max Dale Cooper and Brantley R Herrin. These collaborations have further enriched his research and contributed to the advancement of knowledge in variable lymphocyte receptors.
Conclusion
Matthew N Alder's innovative work in the field of biotechnology, particularly with variable lymphocyte receptors, showcases his commitment to advancing medical science. His contributions through patents and collaborations highlight the importance of innovation in addressing complex health challenges.